Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Octavian Ciurea

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
Advances in haploidentical stem cell transplantationUlas Darda Bayraktar, Marcos de Lima, Stefan Octavian Ciurea
Acta Haematologica|February 26, 2016
Haploidentical Donors: Can Faster Transplantation Be Life-Saving for Patients with Advanced Disease?Alina Tanase, Ciprian Tomuleasa, Alexandra Marculescu, et al.
Transplantation and Cellular Therapy|September 23, 2020
Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular TherapyBhagirathbhai Dholaria, Bipin N Savani, Betty K Hamilton, et al.
Blood Advances|September 22, 2021
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AMLKamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
Advances in haploidentical stem cell transplantationUlas Darda Bayraktar, Marcos de Lima, Stefan Octavian Ciurea
Acta Haematologica|February 26, 2016
Haploidentical Donors: Can Faster Transplantation Be Life-Saving for Patients with Advanced Disease?Alina Tanase, Ciprian Tomuleasa, Alexandra Marculescu, et al.
Transplantation and Cellular Therapy|September 23, 2020
Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular TherapyBhagirathbhai Dholaria, Bipin N Savani, Betty K Hamilton, et al.
Blood Advances|September 22, 2021
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AMLKamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, et al.
Pageof 1